← Leaderboards
Gail G Shapiro
Asthma, Inc.
$998,921
Attributed
$998,921
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $311.4K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$998,921 · 2
By mechanism
U01$998,920 · 1
N01$1 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Adverse Effect”
- Elizabeth A Thom · George Washington University$121,387,653
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- John M Lachin · George Washington University$118,921,924
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,372,214
- Myron S Cohen · Family Health International$101,800,876
Research focus
Drug Adverse EffectAsthmaAdolescence (12-20)Child Physical DevelopmentHuman SubjectLung DevelopmentClinical ResearchPatient Care ManagementCooperative StudyYoung Adult Human (21-34)CorticosteroidsRespiratory Disorder EpidemiologyBody HeightLongitudinal Human StudyRespiratory FunctionBronchodilatorsChild PsychologyDesoxycorticosteroneAntiinflammatory AgentsHuman Therapy EvaluationMiddle Childhood (6-11)Pediatric PharmacologyPediatricsRespiratory Disorder Chemotherapy
Grant awards (5)
CAMP Continuation Study/Phase 2 (CAMPCS/2)$311,420
U01 · FY2006 · HL · contact PI
CAMP Continuation Study/Phase 2 (CAMPCS/2)$261,514
U01 · FY2005 · HL
CAMP Continuation Study/Phase 2 (CAMPCS/2)$244,194
U01 · FY2004 · HL
CAMP Continuation Study/Phase 2 (CAMPCS/2)$181,792
U01 · FY2003 · HL
CLINICAL CENTER FOR CAMP$1
N01 · FY2000 · HR